Eumentis Therapeutics Inc.
PrivateLast Round
Debt
Jun 26, 2024
Total Funding Raised
$36.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Eumentis Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops novel therapeutics for the treatment of neuropsychiatric and neurodevelopmental disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eumentis Therapeutics Inc. Comparables
Compare Eumentis Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noema Pharma | 82% | |
| Merck & Co., Inc. | 79% | |
| Celon Pharma | 78% |
Eumentis Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 26, 2024 | ||||
| Series B | Feb 15, 2023 | ||||
| Grant | Feb 8, 2023 | ||||
| Debt | Apr 15, 2022 | ||||
| Series A | Oct 27, 2020 | ||||
Seed | Sep 2, 2020 |
Eumentis Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Joyance Partners | Seed |
| Social Starts | Seed |
| TCA Venture Group | Series A, Seed |
| Life Science Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 111% MoM.
- Jun 26, 2024
$765K raised in debt financing.
Eumentis Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Eumentis Therapeutics Inc.'s valuation, stock price, and market status.
Is Eumentis Therapeutics Inc. a public or private company?
Eumentis Therapeutics Inc. is a private company.
What is the current stock price of Eumentis Therapeutics Inc.?
Eumentis Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Eumentis Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eumentis Therapeutics Inc. worth (valuation)?
Valuation information for Eumentis Therapeutics Inc. is not publicly available.
Can I buy Eumentis Therapeutics Inc. stock?
Eumentis Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eumentis Therapeutics Inc.'s last funding round?
Eumentis Therapeutics Inc.'s most recent funding round was Debt on June 26, 2024.
Who are the main investors in Eumentis Therapeutics Inc.?
Key investors in Eumentis Therapeutics Inc. include United States Department of Defense, Joyance Partners, Social Starts, TCA Venture Group, Life Science Angels.
Will Eumentis Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Eumentis Therapeutics Inc..
How can I track Eumentis Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Eumentis Therapeutics Inc.'s shares on secondary markets.